What are the specific functions and effects of lenvatinib/lenvatinib and what are their effects?

Lenvatinib is an anti-tumor drug that targets multiple receptor tyrosine kinases. It is an oral small molecule inhibitor. Its mechanism mainly achieves anti-tumor effects by interfering with tumor angiogenesis and tumor cell growth signaling pathways. The therapeutic logic of lenvatinib does not only act on a certain cancer type, but relies on its blocking effect on multiple pathways such as VEGFR (vascular endothelial growth factor receptor) 1-3, FGFR (fibroblast growth factor receptor) 1-4, PDGFRα, RET and KIT, and has shown important biological activity in multiple solid tumors. This broad target range makes its clinical application quite flexible and promising.

In terms of mechanism of action, lenvatinib’s inhibition of angiogenesis has dual significance. On the one hand, by inhibiting the VEGFR family signaling pathway, it effectively prevents the formation of new blood vessels in tumors, thus weakening the ability of tumors to obtain nutrients and oxygen. On the other hand, its inhibition of FGFR provides additional treatment possibilities for certain tumor types such as hepatocellular carcinoma. Especially when tumors develop resistance to a single VEGF inhibitory drug, the multi-target mechanism of lenvatinib can often delay the occurrence of resistance to a large extent and improve the durability of treatment.

From the perspective of therapeutic effect, lenvatinib has achieved positive therapeutic results in many tumor types, especially in kidney cancer, liver cancer and thyroid cancer, and its application frequency is increasing year by year. Common responses of patients after treatment include tumor shrinkage, delayed disease progression, pain relief, etc. These clinical improvements also indirectly reflect its ability to control the biological behavior of tumors. At the same time, due to its oral administration form, compared with intravenous targeted drugs, patient acceptance and compliance are generally higher, which is of great significance for maintaining long-term treatment.

Reference materials:https://www.lenvima.com/